|
DE2617646C2
(de)
*
|
1976-04-22 |
1986-07-31 |
Hoechst Ag, 6230 Frankfurt |
Nonapeptid-amide und Decapeptid-amide mit Gonadoliberin-Wirkung, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
|
|
GB1524747A
(en)
*
|
1976-05-11 |
1978-09-13 |
Ici Ltd |
Polypeptide
|
|
DE2735515A1
(de)
*
|
1977-08-06 |
1979-02-22 |
Hoechst Ag |
Verwendung von lh-rh-peptiden als antikonzeptive
|
|
FR2450109B1
(fr)
*
|
1977-11-08 |
1986-03-28 |
Roussel Uclaf |
Nouvelle methode de traitement utilisant la lh-rh, ou des agonistes
|
|
US4234571A
(en)
*
|
1979-06-11 |
1980-11-18 |
Syntex (U.S.A.) Inc. |
Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
|
|
IT1149971B
(it)
*
|
1979-06-11 |
1986-12-10 |
Syntex Inc |
Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante
|
|
DE3020941A1
(de)
*
|
1980-06-03 |
1981-12-17 |
Hoechst Ag, 6000 Frankfurt |
Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
|
|
HU185535B
(en)
*
|
1982-05-25 |
1985-02-28 |
Mta Koezponti Hivatala |
Process for preparing new gonadoliberin derivatives
|
|
AT390066B
(de)
*
|
1983-03-29 |
1990-03-12 |
Richter Gedeon Vegyeszet |
Verfahren zur herstellung von neuen gonadoliberin-derivaten
|
|
HU187503B
(en)
*
|
1983-03-29 |
1986-01-28 |
Magyar Tudomanyos Akademia,Hu |
Process for preparing gonadoliberine derivatives containing beta-aspartyl group
|
|
DE3411224A1
(de)
*
|
1984-03-27 |
1985-10-10 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zur racematarmen herstellung von peptidzwischenprodukten der gonadorelin- und gonadorelinanaloga-synthese und neue zwischenprodukte bei diesem verfahren
|
|
US4775660A
(en)
*
|
1984-08-02 |
1988-10-04 |
Fernand Labrie |
Treatment of breast cancer by combination therapy
|
|
US4760053A
(en)
*
|
1984-08-02 |
1988-07-26 |
Fernand Labrie |
Combination therapy for selected sex steroid dependent cancers
|
|
US4666885A
(en)
*
|
1985-02-08 |
1987-05-19 |
Fernand Labrie |
Combination therapy for treatment of female breast cancer
|
|
HU193093B
(en)
*
|
1985-04-16 |
1987-08-28 |
Innofinance |
Process for stimulating sexual activity of birds and domestic mammalians and process for producing spermatocytes for their propagation
|
|
HU194280B
(en)
*
|
1985-10-22 |
1988-01-28 |
Richter Gedeon Vegyeszet |
Process for producing new gonadoliberin analogues of high effectivity and pharmaceutical compositions containing them
|
|
US5372996A
(en)
*
|
1989-03-10 |
1994-12-13 |
Endorecherche, Inc. |
Method of treatment of androgen-related diseases
|
|
EP0462189B1
(en)
*
|
1989-03-10 |
1995-09-27 |
Endorecherche Inc. |
Combination therapy for treatment of estrogen sensitive diseases
|
|
JPH0235232A
(ja)
*
|
1989-06-29 |
1990-02-05 |
Nhk Spring Co Ltd |
気室と液室を有する圧力容器
|
|
KR0181264B1
(ko)
*
|
1989-07-07 |
1999-03-20 |
라브리 페르낭 |
성스테로이드 활성 억제용 안드로겐 유도체
|
|
JP3350048B2
(ja)
*
|
1989-07-07 |
2002-11-25 |
アンドルシェルシュ・インコーポレイテッド |
アンドロゲン関連疾患の治療方法
|
|
CA2029018A1
(en)
*
|
1989-11-01 |
1991-05-02 |
Robert P. Millar |
Analogues of gonadotropin releasing hormone
|
|
JPH0474770U
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
1990-10-31 |
1992-06-30 |
|
|
|
EP0641211A1
(en)
*
|
1992-05-21 |
1995-03-08 |
Endorecherche Inc. |
INHIBITORS OF TESTOSTERONE 5$g(a)-REDUCTASE ACTIVITY
|
|
US6413536B1
(en)
|
1995-06-07 |
2002-07-02 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US7833543B2
(en)
*
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
|
CA2192782C
(en)
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
|
US6051558A
(en)
*
|
1997-05-28 |
2000-04-18 |
Southern Biosystems, Inc. |
Compositions suitable for controlled release of the hormone GnRH and its analogs
|
|
US20060025328A1
(en)
*
|
1997-05-28 |
2006-02-02 |
Burns Patrick J |
Compositions suitable for controlled release of the hormone GnRH and its analogs
|
|
US6242421B1
(en)
|
1997-11-06 |
2001-06-05 |
Richard Lloyd Bowen |
Methods for preventing and treating Alzheimer's disease
|
|
ES2154590B1
(es)
|
1999-05-20 |
2001-11-01 |
Lipotec Sa |
Procedimiento de sintesis de peptidos en fase solida
|
|
AR023940A1
(es)
|
2000-05-03 |
2002-09-04 |
Eriochem Sa |
Procedimiento para la produccion de microcapsulas de liberacion prolongada de peptidos solubles en agua
|
|
AU2002324447B2
(en)
*
|
2001-06-22 |
2006-06-29 |
Durect Corporation |
Zero-order prolonged release coaxial implants
|
|
US20060287282A1
(en)
*
|
2001-06-25 |
2006-12-21 |
Steiner Mitchell S |
Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
|
|
US20050215528A1
(en)
*
|
2001-08-10 |
2005-09-29 |
Shuichi Furuya |
Gnrh agonist combination drugs
|
|
EP1444988A4
(en)
|
2001-11-13 |
2007-04-25 |
Takeda Pharmaceutical |
CANCER AGENT
|
|
US20030144203A1
(en)
*
|
2001-12-19 |
2003-07-31 |
Voyager Pharmaceutical Corporation |
Methods for slowing senescence and treating and preventing diseases associated with senescence
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
CA2779723C
(en)
*
|
2002-12-13 |
2014-03-25 |
Durect Corporation |
Oral drug delivery system
|
|
GB0307777D0
(en)
*
|
2003-04-04 |
2003-05-07 |
Medical Res Council |
Conjugate compounds
|
|
US8753665B2
(en)
*
|
2004-09-17 |
2014-06-17 |
Durect Corporation |
Controlled delivery system
|
|
BRPI0606455A
(pt)
|
2005-01-21 |
2008-03-11 |
Astex Therapeutics Ltd |
compostos farmacêuticos
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US7942867B2
(en)
*
|
2005-11-09 |
2011-05-17 |
The Invention Science Fund I, Llc |
Remotely controlled substance delivery device
|
|
WO2008044041A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
US8883790B2
(en)
|
2006-10-12 |
2014-11-11 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
US8337883B2
(en)
|
2006-11-03 |
2012-12-25 |
Durect Corporation |
Transdermal delivery systems
|
|
EP2067471B1
(en)
*
|
2007-12-06 |
2018-02-14 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
|
RU2444525C2
(ru)
*
|
2010-06-09 |
2012-03-10 |
Закрытое Акционерное Общество "Фарм-Синтез" |
Способ получения нонапептидэтиламида и промежуточные соединения для его получения
|
|
CN103037862A
(zh)
|
2010-06-16 |
2013-04-10 |
恩多研究公司 |
治疗或预防雌激素相关疾病的方法
|
|
HK1220579A1
(zh)
|
2013-03-15 |
2017-05-12 |
Durect Corporation |
用於降低溶解可变性的具有流变改性剂的组合物
|
|
CN109475505A
(zh)
|
2016-07-06 |
2019-03-15 |
度瑞公司 |
具有药物组成物、屏障层及药物层的口服剂型
|
|
CN115666621A
(zh)
|
2020-01-13 |
2023-01-31 |
度勒科特公司 |
具有减少的杂质的持续释放药物递送系统及相关方法
|